ARFASETIN 10 bags of 1,5 g

Description

Composition

active substances: blueberry common shoot, beans common leaf of fruits, eleuterococcus prickly rhizome with roots, rosehip fruits, horsetail field grass, St. John’s wort grass, chamomile flowers.

1 g of collection contains: common blueberry shoots – 0.2 g; common beans with fruit flaps – 0.2 g; Eleutherococcus spiny rhizome with roots – 0.15 g; rose hips – 0.15 g; horsetail field grass – 0.1 g; St. John’s wort grass – 0.1 g; chamomile flowers – 0.1 g.

Medicinal form: gathering.

Main physicochemical properties: a mixture of non-homogeneous grayish-green pieces with light yellow, grayish-brown, cream, yellowish-gray, orange-red, brownish-red, brown and white spots; the smell is weak, pleasant.

Pharmacotherapeutic group

Antidiabetic drugs. ATX code A10X.

Pharmacological properties

Pharmacodynamics.

The components of the collection contain essential oil, flavonoids, coumarins, polysaccharides, mineral salts, organic acids, tannins, alkaloids, resinous substances, and bitter substances. This complex of biologically active substances has a hypoglycemic effect in type II diabetes, which makes it possible in some cases to reduce daily doses of oral antidiabetic drugs and increases tolerance to carbohydrates. With type I diabetes, a noticeable hypoglycemic effect was not noted.

Clinical characteristics

Indication

Type II diabetes of mild and moderate severity (as part of complex therapy).

Contraindication

Arterial hypertension, biliary tract dyskinesia, exacerbation of chronic pancreatitis or chronic enterocolitis, nephritis, nephrosis, nephrozonephritis, hyperthermic syndrome, increased excitement, epilepsy, acute infectious diseases, myocardial infarction, arrhythmias, insomnia, neurocirculatory dystonia, thrombophlebitis and predisposition to it, circulatory failure, endocarditis, uncompensated diabetes, severe kidney disease, gallstone disease.

Interaction with other medicinal products and other types of interactions

It is not recommended for patients taking anticoagulants, antibiotics, sulfonamides, contraceptives, hypotensive agents (calcium channel blockers), hypocholesterolemic drugs (statins), female sex hormones, and cardiac glycosides.

The drug can potentiate the effect of drugs that stimulate the central nervous system, analeptics, and hypoglycemic agents, and inhibit the effect of sedative and hypnotic drugs. In complex therapy, it can contribute to the reduction of doses of oral antidiabetic drugs.

Features of application

It is recommended to shake the infusion before use. UV exposure should be avoided during treatment.

When using Arfazetin in combination with antidiabetic drugs, it is necessary to follow the rules of administration, precautions and contraindications provided for oral antidiabetic drugs.

Using during pregnancy or breastfeeding. Contraindicated.

The ability to influence the speed of reaction when driving a motor vehicle or other mechanisms. Although there is no data on the effect of Arfazetin on reaction speed, caution is necessary when using the drug if it is necessary to drive a motor vehicle or operate other mechanisms.

Method of application and dosage

Infusion: place 5 g (1 dessert spoon) of the mixture in an enamel dish, pour 200 ml (1 glass) of hot boiled water, cover with a lid and infuse in a boiling water bath for 15 minutes. Cool at room temperature for 45 minutes, filter, squeeze the residue into the strained infusion. Bring the volume of infusion to 200 ml with boiled water. Take warm, ⅓–½ cup 2-3 times a day 30 minutes before meals for 20-30 days. It is recommended to shake the infusion before use.

Filter bags: place 2 filter bags in a glass or enamel dish, pour 200 ml (1 glass) of boiling water, close and infuse for 15 minutes. Take 1 glass 2 times a day warm, 30 minutes before meals for 20-30 days. After 10-15 days, the course of treatment is recommended to repeat. Conduct 3-4 courses during the year.

Children: apply to children over 12 years of age under the close supervision of a doctor.

Overdose

Increased manifestations of adverse reactions.

Adverse reactions

From the nervous system: excitement, sleep disturbance, irritability, anxiety, decrease in working capacity.

Dermatological reactions: allergic reactions, including hyperemia, rash, itching, swelling of the skin, photosensitization.

From the cardiovascular system: increased blood pressure, tachycardia.

From the urinary system: can cause irritation of the kidney tissue, manifested by pain in the lower back and upon completion of urination.

With long-term use (more than 2 months), it can cause muscle spasm and disorders of the digestive tract.

Expiration date: 2 years.

Storage conditions: store in the original packaging at a temperature not higher than 25 °C. Keep out of the reach of children.

Packaging

50 g or 75 g in packs with an inner bag; 1.5 g in filter bags, 10 filter bags in a package.

Leave category: without a prescription.

Producer: PrJSC Pharmaceutical factory “Viola”.

The location of the manufacturer and its address of the place of business: Ukraine, 69050, m. Zaporozhye, Skladska, 4.

The applicant: PrJSC Pharmaceutical factory “Viola”.

Location of the applicant: Ukraine, 69063, m. Zaporozhye, Akademika Amosova, 75.